Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency

Eur J Dermatol. 2021 Feb 1;31(1):93-94. doi: 10.1684/ejd.2020.3954.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Common Variable Immunodeficiency / complications*
  • Eczema / drug therapy*
  • Eczema / etiology*
  • Exanthema / drug therapy*
  • Exanthema / etiology*
  • Female
  • Humans
  • Middle Aged
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab